Rankings
▼
Calendar
ALKS Q1 2018 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena
ALKS
Alkermes plc
$5B
Q1 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$225M
+17.4% YoY
Gross Profit
$181M
80.2% margin
Operating Income
-$62M
-27.5% margin
Net Income
-$63M
-27.8% margin
EPS (Diluted)
$-0.40
QoQ Revenue Growth
-18.2%
Cash Flow
Operating Cash Flow
-$27M
Free Cash Flow
-$45M
Stock-Based Comp.
$20M
Balance Sheet
Total Assets
$1.7B
Total Liabilities
$581M
Stockholders' Equity
$1.2B
Cash & Equivalents
$187M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$225M
$192M
+17.4%
Gross Profit
$181M
$151M
+19.4%
Operating Income
-$62M
-$71M
+12.7%
Net Income
-$63M
-$69M
+9.3%
Revenue Segments
Manufactured Product And Royalty
$115M
100%
← FY 2018
All Quarters
Q2 2018 →